BioSpace News Archive

Syapse®, a real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today announced the appointment of David Pomerantz as Chief Commercial Officer. Mr. Pomerantz brings more than 25 years of account management, commercial and operational experience in the area of real-world evidence for life sciences having most recently come from Kantar Health, a leader in providing data,

Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its virtual Investor Day held over two days: Monday, September 14, 2020 from 1:00 p.m. EDT to 4:00 p.m. EDT and Tuesday, September 15, 2020 from 10:00 a.m. EDT to 1:00 p.m. EDT. Pfizer business executives and scientific leadership will provide updates on the company’s progress in advancing its R&D pipeline, specifically on pro

Children who live with life-threatening food allergies are already at a higher risk of an anaphylactic reaction, and the COVID-19 pandemic creates a significant health risk. The Southern California Food Allergy Institute (SCFAI) has created a COVID-safe zone to continue to deliver life-saving treatment for more than 10,000 pa

Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation devices for the treatment of urinary and bowel dysfunction, announced that Raymond W. Cohen, CEO of Axonics, will participate in the following upcoming investor conferences

McMaster HealthLabs, Air Canada and the Greater Toronto Airports Authority announced that they will partner on a voluntary COVID-19 study of international travellers arriving at Toronto Pearson International Airport.

InspireMD, Inc. announces the award for Best ESC Congress Poster for the presentation of updated data from the large, long-term PARADIGM-EXTEND study of the CGuard™ Embolic Prevention System, as part of the European Society of Cardiology 2020 Carotid Update e-presentation at the European Society of Cardiology Congress 2020.

Karuna Therapeutics, Inc. announced that senior management will participate in the following upcoming virtual investor conferences

Boston Scientific announced that the U.S. Centers for Medicare and Medicaid Services granted a New Technology Add-on Payment for the Eluvia™ Drug-Eluting Vascular Stent System as part of the 2021 Inpatient Prospective Payment System.

AVROBIO, Inc., a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, announced that members of its senior management team are scheduled to participate in three upcoming virtual investor conferences.

BELLUS Health Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, announced that Roberto Bellini, President and Chief Executive Officer of BELLUS Health, will participate in two upcoming virtual healthcare investor conferences.